Payer PolicyActive
CMM-207: Epidural Adhesiolysis
EVICORE-MSK_ADVANCED-E60565CA
EviCore by Evernorth
Effective: July 1, 2021
Updated: January 13, 2026
created · Dec 5, 2025
Policy Summary
Epidural adhesiolysis (catheter- or endoscopy-based), including catheter manipulation or injection of saline/adhesiolytic agents, is considered experimental, investigational, or unproven for treatment of back pain and therefore not covered; CPT codes 62263, 62264, 62280, 62281, and 62282 are listed as EIU. Key points: there is insufficient scientific evidence to support its use, no covered indications or documentation requirements are provided, and final reimbursement decisions rest with the individual health plan.
Coverage Criteria Preview
Key requirements from the full policy
"Epidural adhesiolysis, performed by catheter or endoscopically, as a treatment for back pain is considered experimental, investigational or unproven (EIU)."
Sign up to see full coverage criteria, indications, and limitations.